Highly accurate and label-free discrimination of single cancer cell using a plasmonic oxide-based nanoprobe.
Colorimetric cell detection
Plasmon oxide
Single cell detection
Surface enhanced Raman spectroscopy
Journal
Biosensors & bioelectronics
ISSN: 1873-4235
Titre abrégé: Biosens Bioelectron
Pays: England
ID NLM: 9001289
Informations de publication
Date de publication:
15 Feb 2022
15 Feb 2022
Historique:
received:
01
08
2021
revised:
01
11
2021
accepted:
14
11
2021
pubmed:
27
11
2021
medline:
5
1
2022
entrez:
26
11
2021
Statut:
ppublish
Résumé
The detection of cancer cells at the single-cell level enables many novel functionalities such as next-generation cancer prognosis and accurate cellular analysis. While surface-enhanced Raman spectroscopy (SERS) has been widely considered as an effective tool in a low-cost and label-free manner, however, it is challenging to discriminate single cancer cells with an accuracy above 90% mainly due to the poor biocompatibility of the noble-metal-based SERS agents. Here, we report a dual-functional nanoprobe based on dopant-driven plasmonic oxides, demonstrating a maximum accuracy above 90% in distinguishing single THP-1 cell from peripheral blood mononuclear cell (PBMC) and human embryonic kidney (HEK) 293 from human macrophage cell line U937 based on their SERS patterns. Furthermore, this nanoprobe can be triggered by the bio-redox response from individual cells towards stimuli, empowering another complementary colorimetric cell detection, approximately achieving the unity discrimination accuracy at a single-cell level. Our strategy could potentially enable the future accurate and low-cost detection of cancer cells from mixed cell samples.
Identifiants
pubmed: 34823964
pii: S0956-5663(21)00851-4
doi: 10.1016/j.bios.2021.113814
pii:
doi:
Substances chimiques
Oxides
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
113814Informations de copyright
Copyright © 2021 Elsevier B.V. All rights reserved.